Lastname Organization Clinical Trials State / Region Country
Eugenio Zapata-Aldana London Health Science Centre Canada
Andrea Swenson
Principal Investigator
University of Iowa Iowa United States
Kara Steijlen
Principal Investigator
Henry Ford Hospital Michigan United States
Zachary Simmons
Principal Investigator
Penn State Hershey Medical Center Pennsylvania United States
Jennifer Roan United States
Patty Riley CSL Behring MG-SCIg (ends 2022) Pennsylvania United States
Nataly Montes-Chinea United States
Janice Massey
Select a Country
Veronica Martin
Study Coordinator
University of California, Irvine Methotrexa (ends 2019), Rasagiline (ends 2021) California United States
Jean Mah
Select a Country
Jau-Shin Lou
Principal Investigator
Sanford Health North Dakota United States
Chamindra Konersman University of California, San Diego California United States
Chafic Karam
Principal Investigator
Oregon health science university Rasagiline (ends 2021) Oregon United States
Yessar Hussain
Principal Investigator
Austin Neuromuscular Center Rasagiline (ends 2021), n/a Texas United States
James Howard
Principal Investigator
University of North Carolina at Chapel Hill FOR-DMD (ends 2024), Methotrexa (ends 2019) North Carolina United States
Michael Hehir
Principal Investigator
University of Vermont Larner College of Medicine EPITOME I (ends 2018) Vermont United States
Laura Friudenberg
Select a Country
Bakri Elsheikh
Co-investigator
The Ohio State University Wexner Medical Center MG-SCIg (ends 2022), Methotrexa (ends 2019), n/a Ohio United States
Christyn Edmundson
Principal Investigator
University of Pennsylvania Pennsylvania United States
Dubravka Dodig
Clinical Evaluator
University Health Network Canada